Resumen de SEOM clinical guidelines on cardiovascular toxicity (2018)

Juan Antonio Virizuela Echaburu, Ana Martín García, Ramón de las Peñas Bataller, Ana Santaballa Bertrán, Raquel Andrés Conejero, Carmen Beato Zambrano, Susana de la Cruz Sánchez, Joaquín Gavilá Gregori, Santiago González Santiago, T. López Fernández

• One of the most common side effects of cancer treatment is cardiovascular disease, which substantially impacts long-term survivor’s prognosis. Cardiotoxicity can be related with either a direct side effect of antitumor therapies or an accelerated development of cardiovascular diseases in the presence of preexisting risk factors. Even though it is widely recognized as an alarming clinical problem, scientific evidence is scarce in the management of these complications in cancer patients. Consequently, current recommendations are based on expert consensus. This Guideline represents SEOM’s ongoing commitment to progressing and improving supportive care for cancer patients.